Search News
| 0.15 Delayed Data As of Apr 25 |  0.00 / 0.00%Today’s Change | 0.06 Today|||52-Week Range 0.49 | +50.30% Year-to-Date |
| Previous close | 0.15 |
| Today’s open | 0.11 |
| Day’s range | 0.11 - 0.15 |
| Volume | 21,000 |
| Average volume (3 months) | 22,432 |
| Market cap | $1.3M |
| Earnings growth (last year) | -419.51% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$16.0M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President & Director Eric A. Clemons |
Chief Financial Officer, Secretary & Director Wesley D. Tate |
Corporate headquarters Costa Mesa, California |
